WallStreetZenWallStreetZen

NASDAQ: IMGN
Immunogen Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for IMGN

Based on 7 analysts offering 12 month price targets for Immunogen Inc.
Min Forecast
$16.00+1.46%
Avg Forecast
$23.00+45.85%
Max Forecast
$27.00+71.21%

Should I buy or sell IMGN stock?

Based on 7 analysts offering ratings for Immunogen Inc.
Strong Buy
Strong Buy
5 analysts 71.43%
Buy
2 analysts 28.57%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IMGN stock forecasts and price targets.

IMGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
JP Morgan
Bottom 26%
26
Strong BuyUpgrades$22.00+39.51%2023-09-13
HC Wainwright & Co.
Bottom 1%
1
BuyMaintains$27.00+71.21%2023-08-29
Barclays
Bottom 14%
14
Strong BuyMaintains$27.00+71.21%2023-08-02
Canaccord Genuity
Bottom 15%
15
Strong BuyMaintains$25.00+58.53%2023-08-01
BMO Capital
Top 8%
93
BuyMaintains$26.00+64.87%2023-08-01
Truist Securities
Bottom 7%
7
Strong BuyMaintains$18.00+14.14%2023-06-06
Piper Sandler
Bottom 8%
8
Strong BuyUpgrades$16.00+1.46%2023-05-03

1 of 1

Forecast return on equity

Is IMGN forecast to generate an efficient return?
Company
N/A
Industry
0.66%
Market
28.71%

Forecast return on assets

Is IMGN forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.05%

IMGN revenue growth forecast

How is IMGN forecast to perform vs Biotechnology companies and vs the US market?
Company
38.87%
Industry
34.31%
Market
8.24%
IMGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IMGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IMGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMGN$15.77$23.00+45.85%Strong Buy
BBIO$25.41$42.00+65.29%Strong Buy
INSM$25.37$46.33+82.63%Strong Buy
MLTX$57.58$71.00+23.31%Buy
DNA$1.71$1.25-26.90%Strong Sell
View Top Biotech Stocks

Immunogen Stock Forecast FAQ

Is Immunogen Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: IMGN) stock is to Strong Buy IMGN stock.

Out of 7 analysts, 5 (71.43%) are recommending IMGN as a Strong Buy, 2 (28.57%) are recommending IMGN as a Buy, 0 (0%) are recommending IMGN as a Hold, 0 (0%) are recommending IMGN as a Sell, and 0 (0%) are recommending IMGN as a Strong Sell.

If you're new to stock investing, here's how to buy Immunogen stock.

What is IMGN's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: IMGN) forecast ROE is N/A, which is considered weak.

What is IMGN's Price Target?

According to 7 Wall Street analysts that have issued a 1 year IMGN price target, the average IMGN price target is $23.00, with the highest IMGN stock price forecast at $27.00 and the lowest IMGN stock price forecast at $16.00.

On average, Wall Street analysts predict that Immunogen's share price could reach $23.00 by Sep 13, 2024. The average Immunogen stock price prediction forecasts a potential upside of 45.85% from the current IMGN share price of $15.77.

What is IMGN's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: IMGN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.05%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.